Quoin Pharmaceuticals
QNRX
1 hedge funds and large institutions have $342K invested in Quoin Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
48% less capital invested
Capital invested by funds: $664K → $342K (-$322K)
75% less funds holding
Funds holding: 4 → 1 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$174K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$84K |
| 3 |
HF
HRT Financial
New York
|
-$56K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$34K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $320K | -$174K | -4 | -36% |
|
2
Morgan Stanley
New York
| $22K | – | – | – |
|
|
WS
3
Wedbush Securities
Los Angeles,
California
| – | -$84K | -2 | Closed |
|
|
HF
4
HRT Financial
New York
| – | -$56K | -1 | Closed |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$34K | -1 | Closed |
|
|
ASN
6
Advisory Services Network
Atlanta,
Georgia
| – | -$2K | – | – |
|
QNRX Hedge Fund Activity: Q4 2020 in Review
1 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q4 2020, worth a combined $342K — down 48% from $664K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of QNRX and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $174K.
- 1 institutional investor held Quoin Pharmaceuticals (QNRX) as of Q4 2020, down from 4 in Q3 2020.
- Funds reported $342K of Quoin Pharmaceuticals stock for Q4 2020, down 48% quarter-over-quarter.
- 0 funds opened new Quoin Pharmaceuticals positions in Q4 2020 and 3 closed out, a net change of -3 holders.
- The largest Quoin Pharmaceuticals seller in Q4 2020 was Renaissance Technologies, an estimated $174K sold.
Based on aggregated 13F filings for Q4 2020.